UPDATE: China Pharma Holdings, Inc. (CPHI) Reports Q2 EPS of $0.00 on Revenues of $3.77M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results
August 14, 2020 6:30 AM EDTHAIKOU CITY, China, Aug. 14, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended June 30, 2020.
Second Quarter Highlights
Revenue increased 46.8% to $3.8 million in the second quarter 2020 from $2.6 million in the same period of 2019; Gross margin was 30.5% in the second quarter 2020, compared to 6.4% in the same period of 2019; Income from operations was $0.1 million in the second quarter 2020... More